
Sign up to save your podcasts
Or


Michael Cloonan, CEO of Sionna Therapeutics, shares his insights about leadership in biopharma and how Sionna is working to restore the cystic fibrosis transmembrane conductance regulator for people living with cystic fibrosis.
By John Simboli5
77 ratings
Michael Cloonan, CEO of Sionna Therapeutics, shares his insights about leadership in biopharma and how Sionna is working to restore the cystic fibrosis transmembrane conductance regulator for people living with cystic fibrosis.

3,072 Listeners

1,993 Listeners

1,105 Listeners

2,342 Listeners

943 Listeners

797 Listeners

125 Listeners

337 Listeners

6,097 Listeners

95 Listeners

10,254 Listeners

551 Listeners

152 Listeners

248 Listeners

187 Listeners